X0202 SCHEDULE 13G/A 0001876264 XXXXXXXX LIVE 2 Ordinary Shares, par value CHF 0.01 per share 03/31/2026 0001953530 Oculis Holding AG H5870P102 Bahnhofstrasse 20 Zug V8 CH-6300 Rule 13d-1(d) LSP 7 Cooperatieve U.A. P7 0 6950294 0 6950294 6950294 N 11.8 OO LSP 7 Management B.V. P7 0 6950294 0 6950294 6950294 N 11.8 OO Oculis Holding AG Bahnhofstrasse 20, CH-6300, Zug, Switzerland Each of the following is hereinafter individually referred to as a "Reporting Person" and collectively as the "Reporting Persons." This statement is filed on behalf of: LSP 7 Cooperatieve U.A. ("LSP 7"); and LSP 7 Management B.V. The principal business address of each of the Reporting Persons is c/o EQT Life Sciences, Johannes Vermeerplein 9, 1071 DV Amsterdam, the Netherlands. Each of the Reporting Persons is organized under the laws of the Netherlands. Y The ownership information presented herein represents beneficial ownership of Ordinary Shares of the Issuer as of March 31, 2026, based on 59,034,438 Ordinary Shares outstanding, which consists of (i) 57,984,438 Ordinary Shares outstanding as of December 31, 2025, as disclosed in the Issuer's annual report on Form 20-F filed on March 4, 2026, and (ii) 1,050,000 Ordinary Shares purchased by LSP 7 on March 11, 2026. LSP 7 is the record holder of 6,950,294 Ordinary Shares. LSP 7 Management B.V. is the sole director of LSP 7. The managing directors of LSP 7 Management B.V. are Martijn Kleijwegt, Rene Kuijten and Joachim Rothe. As such, LSP 7 Management B.V., Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may be deemed to beneficially own the Ordinary Shares held of record by LSP 7. Each of Mr. Kleijwegt, Mr. Kuijten and Mr. Rothe disclaims beneficial ownership of such shares. 11.8% 0 6,950,294 0 6,950,294 Y Y Y Y Y Y Joint Filing Agreement (previously filed). LSP 7 Cooperatieve U.A. By: LSP 7 Management B.V., its managing director, /s/ Martijn Kleijwegt 04/29/2026 By: LSP 7 Management B.V., its managing director, /s/ Rene Kuijten 04/29/2026 LSP 7 Management B.V. /s/ Martijn Kleijwegt 04/29/2026 /s/ Rene Kuijten 04/29/2026